Pnc Financial Services Group, Inc. Otonomy, Inc. Transaction History

Pnc Financial Services Group, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 09, 2018	SELL	$2.6 - $3.95 $520 - $790	-200 Closed	0 $0
Q2 2018 Aug 10, 2018	SELL	$3.7 - $4.75 $8,506 - $10,920	-2,299 Reduced 92.0%	200 $0
Q3 2017 Nov 13, 2017	BUY	$3.2 - $20.8 $7,996 - $51,979	2,499	2,499 $0

Ticker OTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,990,400
Description
Otonomy, Inc., a biopharmaceutical company, develops therapeutics for neurotology in the United States. The company offers OTO-313, a sustained-exposure formulation of N-methyl-D-aspartate receptor antagonist gacyclidine, which is in Phase II clinical trials to treat tinnitus; and OTO-413, a sustained-exposure formulation of brain-derived neurot...

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.